Cazzola, M. (2010). The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 4(4), 195-198 [10.1177/1753465810377636].
The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.
CAZZOLA, MARIO
2010-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.